Abstract
Aims and Background Patients with a history of Kawasaki disease (KD), especially those with diagnosed coronary artery involvement, are known to require long-term cardiac care. However, specific evidence-based recommendations on long-term medical strategies are missing. Cardiac catheterization (CC) is still considered the gold-standard for diagnosing detailed coronary pathology. Therefore, and to better understand coronary artery pathology development in the long-term, we conducted a survey to document and evaluate CC data in a European population. Here we describe initial data on the first catheter examination these patients underwent.
Method We administered a standardized questionnaire to retrospectively analyze CC data from KD children from the year 2010 until April 2023. This register covers basic acute phase clinical data and, more importantly, detailed information on morphology, distribution and the development of coronary artery pathologies. Data on participating departments of pediatric cardiology, mainly from Germany, were evaluated, with this study focusing on investigating each patient’s first CC exclusively.
Results We analyzed a total of 164, mainly Caucasian, patients (65% male) across 14 pediatric cardiology departments. A relevant number of patients had no coronary artery aneurysm at the CC, facing the fact that distal CAAs were almost exclusively detected alongside proximal CAAs. Patients with multiple CAAs revealed a significant positive correlation between the number of CAAs and their dimensions, in diameter, as in length. Location of the CAA within the coronary artery, age at KD’s onset or gender did not significantly influence CAA diameters, but CAAs were longer in older children and in males.
Conclusion The fact of distal CAAs being only present together with proximal ones, will hopefully reduce diagnostic CCs in KD patients without echocardiographically detected proximal CAAs. Furthermore this study gives valuable insights into dimensional specifics of CAAs in KD patients. As an ongoing register, future analyses will further explore long-term outcomes and performed treatments, helping to refine clinical long-term strategies for KD patients.
Clinical perspective
In Caucasian Kawasaki disease (KD) patients, distal coronary artery aneurysms (CAA) are usually diagnosed in association with proximal CAAs. Additional imaging such as conventional coronary artery angiography may therefore be unnecessary, if no aneurysms are detectable echocardiographically.
In this context, potentially unnecessary CCs hopefully will reduce in future.
Not only the CAA diameters, but also CAA length and CAA count may influence cardiac related morbidity and should be considered in long-term follow-up care.
The age at the acute phase of KD, such as gender and location of CAA within the coronary arteries seems to not affect CAA dimensions.
Clinical Trial Registration Cardiac Catheterization in Kawasaki Disease – data from the central European registry from 2010 – today
DRKS-ID: DRKS00031022, Date of Registration: 16.01.2023
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Cardiac Catheterization in Kawasaki Disease - data from the central European registry from 2010 - today DRKS-ID: DRKS00031022, Date of Registration: 16.01.2023
Funding Statement
none
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical consent from the "Ethikkommission LMU Munich", Pettenkoferstrasse 8, 80336 München, Project-Nr:19-997, date of approval 17.03.2020
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data, consistent with the declareation of Helsinki and German data protection law, are available upon request.
Non-standard Abbreviations and Acronyms
- KD
- Kawasaki Disease
- CC
- Cardiac Catheterization
- CAA
- Coronary Artery Aneurysm
- AP
- Acute Phase
- IVIG
- Intravenous Immunoglobulin
- AHA
- American Heart Association
- JCS
- Japanese Circulation Society
- IQR
- Interquartile Range
- BSA
- Body Surface Area
- RCA
- Right Coronary Artery
- LCA
- Left Coronary Artery
- LAD
- Left Anterior Descending Coronary Artery
- LCX
- Left Circumflex Coronary Artery
- SNP
- Single Nucleotide Polymorphism
- ITPKC
- Inositol 1,4,5-trisphosphate 3-kinase C
- MMP
- Matrix Metalloproteinases